15-Keto-PGE2 acts as a biased/partial agonist to terminate PGE2-evoked signaling.
Ontology highlight
ABSTRACT: Prostaglandin E2 (PGE2) is well-known as an endogenous proinflammatory prostanoid synthesized from arachidonic acid by the activation of cyclooxygenase-2. E type prostanoid (EP) receptors are cognates for PGE2 that have four main subtypes: EP1 to EP4. Of these, the EP2 and EP4 prostanoid receptors have been shown to couple to Gαs-protein and can activate adenylyl cyclase to form cAMP. Studies suggest that EP4 receptors are involved in colorectal homeostasis and cancer development, but further work is needed to identify the roles of EP2 receptors in these functions. After sufficient inflammation has been evoked by PGE2, it is metabolized to 15-keto-PGE2 Thus, 15-keto-PGE2 has long been considered an inactive metabo
SUBMITTER: Endo S
PROVIDER: S-EPMC7504929 | biostudies-literature | 2020 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA